Market Notice

  • There is currently a price interruption. If it is a product with a single price fixing on the day, please note the underlying trading model. Trading is not possible at the moment.

Bristol-Myers Squibb Co./Faktor/Long [12]/SOC

Product class

Factor - Factor Warrant - with Leverage

First exchange day

23/04/2025

Last exchange day

Open End

Performance (1M)

133.33%

Factor type

long

Factor

12.00

Trade further factor warrants for Bristol-Myers Squibb Company without exchange fees.

Facts & figures

Price data

TRADE PLATFORMBörse Stuttgart (XSTU)
LAST PRICE0.043 G0 Units
PRICE DETERMINATION TIME07/22/2026 / 04:30:07 PM
DAILY VOLUME (UNITS)0
DAILY HIGH / LOW0.0430.04
PREV. DAY'S PRICE0.035 (07/21)
CHANGE DAY BEFORE
+0.01
22.86 %
52 WEEK HIGH / LOW1.2 (07/24)0.014 (06/18)

Master Data

WKN
SX7975
ISIN
DE000SX79757
SYMBOL
-
EXCHANGE SEGMENT
Freiverkehr
TYPE OF FINANCIAL INSTRUMENT
Leverage Product
PRODUCT CLASS
Factor - Factor Warrant - with Leverage
PRODUCT NAME
Faktoroptionsschein Long auf Bristol-Myers Squibb Co.
ISSUER
Société Générale Effekten GmbH
TRADING SEGMENT
EUWAX
FACTOR TYPE
long
UNDERLYING
BRISTOL-MYERS SQUIBB CO COM USD0.10
UNDERLYING INSTRUMENT
BRISTOL-MYERS SQUIBB CO COM USD0.10
FACTOR
12.00
MULTIPLIER
1.00
EXERCISE TYPE
American
TRADING CURRENCY NOTE
Euro / Units
NOMINAL CURRENCY
EUR
SETTLEMENT CURRENCY
Euro
SMALLEST TRADABLE UNIT
1.00
MINIMUM QUOTATION EUR
3,000.00
MINIMUM QUOTATION UNITS
10,000.00
LAST VALUATION DAY
Open End
PAYMENT DATE
-
FIRST EXCHANGE DAY
23/04/2025
LAST EXCHANGE DAY
Open End
TRADING HOURS
08:00:00 AM - 10:00:00 PM
QUOTATION
fortlaufende Auktion
ISSUE VOLUME
10,000,000
QUANTO
No

Issuer

NAME
Société Générale Effekten GmbH
ADDRESS
SOCIETE GENERALE Neue Mainzer Straße 46-50 60311 Frankfurt am Main Deutschland
EMAIL ADDRESS
service.zertifikate@sgcib.com
SERVICE PHONE NUMBER
0800 8183050 (Germany only)
URLhttp://www.sg-zertifikate.de

Product Description

This factor warrant provides the investor with a constant leverage of 12.00 to participate in the positive and negative performance of the Bristol-Myers Squibb Co., which is the underlying instrument. This product has an unlimited term. The issuer has the right to terminate the warrant, subject to a specific notice period.